Recent Updates
Recently added Catalysts
ABVC

ABVC BIOPHARMA, INC. 44370 Old Warm Springs Blvd., Fremont, CA 94538 NOTICE OF 2022 ANNUAL MEETING OF SHAREHOLDERS To the Shareholders of ABVC BioPharma, Inc.: You are cordially invited to attend the 2022 annual sharehol

Key Takeaway: Old Warm Springs Blvd., Fremont, CA 94538 OF 2022 ANNUAL MEETING OF SHAREHOLDERS the Shareholders of ABVC BioPharma, Inc.: are cordially invited to attend the 2022 annual shareholder meeting of ABVC BioPharma, Inc. (the "Company" or "ABVC") to be held on May 20, 2022 at 9:00

Full Press Release Details

Old Warm Springs Blvd., Fremont, CA 94538
OF 2022 ANNUAL MEETING OF SHAREHOLDERS
the Shareholders of ABVC BioPharma, Inc.:
are cordially invited to attend the 2022 annual shareholder meeting of ABVC BioPharma, Inc. (the "Company" or "ABVC")
to be held on May 20, 2022 at 9:00 p.m., local time in Taiwan (or 9:00 a.m. EST), as a virtual electronic meeting using a Zoom video
webinar (the "Meeting"). Due to concerns regarding the coronavirus pandemic and to assist in protecting the well-being and
health of our shareholders and employees, the Meeting will be held virtually via the Internet only with no physical in-person meeting
excluding the Board of Directors. Technology will be incorporated into the Meeting to increase efficiency, allow for social distancing
and provide for shareholder participation. In addition to on-line attendance, shareholders can hear all portions of the Meeting, submit
written questions during the Meeting and listen to live responses to shareholder questions.
attend the virtual Meeting, go to the Zoom link below:
you register with your name and email address, so that we can log attendees, you will be taken into the waiting room until the meeting
proxy statement is furnished in connection with the solicitation of proxies by the Board of Directors (the "Board" )
of ABVC BioPharma, Inc. (the "Company" ) for use at the 2022 annual meeting of Shareholders of the
Company (the "Meeting" ) and at all adjournments and postponements thereof. The Meeting will be held
on May 20, 2022, at 9:00 p.m., local time in Taiwan (or 9:00 a.m. EST), to consider and vote upon the following proposals:
1. To re-elect Eugene Jiang, Dr. T.S. Jiang, Dr. Tsang Ming Jiang, Norimi Sakamoto, Yen-Hsin Chou, Dr. Chang-Jen Jiang, Dr. Shin-Yu Miao, and Yoshinobu Odaira, (the "Current Director Nominees" ) to serve on the Company's Board of Directors (the " Board ") until the next annual shareholders meeting and until their successors are duly elected and qualified;
2. To elect Che Wei Hsu, Shuling Jiang and Kuang-Tseng Chen, (the "New Director Nominees," together with the Current Director Nominees , the " Director Nominees" ) to serve on the Company's Board of Directors (the " Board ") until the next annual shareholders meeting and until their successors are duly elected and qualified;
3. To ratify the selection of KCCW Accountancy Corp. (" KCCW ") as our independent auditor to audit the financial statements for the fiscal year ending on December 31, 2022;
4. To approve, by a non-binding vote, the Company's executive compensation;
5. To approve, by a non-binding vote, the frequency of future Stockholder advisory votes relating to the Company's executive compensation; and,
6. To transact such other business as may properly come before the Meeting or any adjournment or postponement thereof.
BOARD UNANIMOUSLY RECOMMENDS A VOTE "FOR" ALL OF THE NOMINEES LISTED ABOVE AND "FOR" EACH OF THE OTHER PROPOSALS
EXCEPT "THREE YEARS" FOR PROPOSAL NO. 5.
of record of the Company's Common Stock at the close of business on April 20, 2022 (the "Record Date")
will be entitled to notice of, and to vote at, this Meeting and any adjournment or postponement thereof. Each share of Common Stock entitles
the holder thereof to one vote.
vote is important, regardless of the number of shares you own. Due to the virtual nature of the Meeting, you are urged to vote in favor
of each of the proposals by so indicating on the enclosed Proxy and by signing and returning the enclosed Proxy as promptly as possible,
before 11:59 p.m. EST on May 19, 2022, whether or not you plan to attend the Meeting virtually. The enclosed Proxy is solicited by
the Company's Board of Directors. Any shareholder giving a Proxy may revoke it prior to the time it is voted by notifying the
Secretary, in writing, to that effect, by filing with him/her a later dated Proxy. You will not be able to vote at the Meeting; therefore,
it is strongly recommended that you complete the enclosed proxy card before 11:59 p.m. EST on May 19, 2022, to ensure that your shares
will be represented at this Meeting.
complete list of Shareholders of record entitled to vote at this Meeting will be available for ten days before this Meeting at the principal
executive office of the Company for inspection by Shareholders during ordinary business hours for any purpose germane to this Meeting.
or not you plan to attend the annual meeting, we urge you to read this notice carefully and to vote your shares. Your vote is very important.
If you are a registered shareholder, please vote your shares as soon as possible by completing, signing, dating and returning the
enclosed proxy card in the postage-paid envelope provided. If you hold your shares in "street name" through a bank, broker
or other nominee, you will need to follow the instructions provided to you by your bank, broker or other nominee to ensure that your
shares are represented and voted at the annual meeting. If you sign, date and return your proxy card without indicating how you wish
to vote, your proxy will be voted FOR each of the proposals to be considered at the annual meeting.
want to thank all of our shareholders as we look forward to what we believe will be an exciting future for our business.
strongly encourage you to vote by proxy as described in the Proxy Statement so that your vote can be counted.
notice and the enclosed proxy statement are first being mailed to Shareholders on or about April 27, 2022.
are urged to review carefully the information contained in the enclosed proxy statement prior to deciding how to vote your shares.
By Order of the Board,
/s/ Howard Doong
Howard Doong
Chief Executive Officer
April 20, 2022
YOU RETURN YOUR PROXY CARD WITHOUT AN INDICATION OF HOW YOU WISH TO VOTE, YOUR SHARES WILL BE VOTED "FOR" ALL OF THE NOMINEES
LISTED ABOVE AND "FOR" EACH OF THE OTHER PROPOSALS.
Notice Regarding the Availability of Proxy Materials
the Annual Shareholder Meeting to Be Held at 9:00 p.m., local time in Taiwan (or 9:00 a.m. EST) on
May 20, 2022 Eastern Standard Time
Notice of Annual Meeting, proxy statement and Annual Report on Form 10-K for year ended December 31, 2021 are available at www.proxyvote.com.
Page
QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS 1
THE ANNUAL MEETING 5
General 5
Date, Time and Place of the Meeting 5
Purpose of the Meeting 5
Record Date and Voting Power 5
Quorum and Required Vote 5
Revocability of Proxies 5
Proxy Solicitation Costs 6
No Right of Appraisal 6
Who Can Answer Your Questions About Voting Your Shares 6
Principal Offices 6
PROPOSAL NO. 1 - RE-ELECTION OF DIRECTORS 6
Board Qualifications and Director Nominees 6
Information Regarding the Company's Directors and Nominees 7
Vote Required 8
PROPOSAL NO. 2 - ELECTION OF DIRECTORS 8
Board Qualifications and Director Nominees 8
Information Regarding the Company's Directors and Nominees 8
Vote Required 8
Recommendation of the Board 8
Corporate Governance 9
Security Ownership of Certain Beneficial Owners and Management 15
Certain Relationships and Related Party Transactions 16
PROPOSAL NO. 3 - RATIFICATION OF SELECTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 20
Principal Accountant Fees and Services 20
Policies and Procedures Relating to Approval of Services by our Independent Registered Public Accountants 20
Vote Required 21
Recommendation of the Board 21
PROPOSAL NO. 4 - ADVISORY VOTE ON EXECUTIVE COMPENSATION 21
Purpose 21
Vote Required 21
Recommendation of the Board 21
PROPOSAL NO. 5 - ADVISORY VOTE ON FREQUENCY OF ADVISORY VOTES ON EXECUTIVE COMPENSATION 21
Purpose 21
Vote Required 22
Recommendation of the Board 22
OTHER INFORMATION 22
Deadline for Submission of Shareholder Proposals for 2023 Annual Meeting of Shareholders 22
Proxy Solicitation 23
Annual Report 23
Delivery of Proxy Materials to Households 23
Where You Can Find Additional Information 23
ANNUAL MEETING OF SHAREHOLDERS
be held on May 20, 2022, at 9:00 p.m., local time in Taiwan, 9:00 a.m. Eastern Standard Time
AND ANSWERS ABOUT THESE PROXY MATERIALS
am I receiving this proxy statement?
notice provides some details about the proposals on which our Board would like you, as a stockholder, to vote at the Meeting, which will
take place at 9:00 p.m., local time in Taiwan (or 9:00 a.m. EST) , on Friday, May 20, 2022 via the Zoom link below. Due to the continued
public health impact of the coronavirus, or COVID-19, the Company has decided to hold the Annual Meeting of Shareholders as a virtual
electronic meeting using Zoom video webinar. To assist in protecting the well-being and health of our shareholders and employees, the
Meeting will be held virtually via the Internet only with no physical in-person meeting except the Board of Directors. In addition
to on-line attendance, shareholders can hear all portions of the Meeting, submit written questions during the Meeting and listen to live
responses to shareholder questions.
attend the virtual Meeting via Zoom, go to the link below:
you register with your name and email address, so that we can log attendees, you will be taken into the waiting room until the meeting
recommend you log in at least 15 minutes before the Meeting to ensure you are logged in when the meeting starts.
are being asked to consider and vote upon proposals to (i) re-elect the Current Director Nominees to the Board to serve one-year terms,
(ii) elect the New Director Nominees to the Board to serve one-year term, (iii) ratify the selection of KCCW as our independent registered
public accounting firm for 2022, (iv) approve, by a non-binding vote, the Company's executive compensation; (v) approve, by a non-binding,
vote the frequency of future Stockholder advisory votes relating to the Company's executive compensation; and (vi) transact such
other business as may properly come before the Meeting or any adjournment or postponement thereof.
proxy statement also gives you information on the proposals so that you can make an informed decision. You should read it carefully. Your
vote is important. You are encouraged to submit your proxy card as soon as possible after carefully reviewing this proxy
this proxy statement, we refer to ABVC BioPharma, Inc. as the "Company", "we", "us" or "our."
can vote at this Meeting?
who owned shares of our common stock, $0.001 par value per share (the "Common Stock") on April 20, 2022
(the "Record Date") may attend and vote at this Meeting. There were 30,307,329 shares of Common Stock
outstanding on the Record Date. All shares of Common Stock shall have one vote per share. Information about the stockholdings of our
directors, executive officers and significant Shareholders is contained in the section of this proxy statement entitled
"Security Ownership of Certain Beneficial Owners and Management" beginning on page 19 of this proxy
card enables you to appoint Howard Doong as your representative at this Meeting. By completing and returning the proxy card, you are
authorizing these persons to vote your shares at this Meeting in accordance with your instructions on the proxy card. This way, your
shares will be voted whether or not you attend this Meeting. Even if you plan to attend this Meeting, it is strongly recommended to complete
and return your proxy card before 11:59 p.m. EST on May 19, 2022 in case your plans change. If a proposal comes up for vote at this Meeting
that is not on the proxy card, the proxies will vote your shares, under your proxy, according to their best judgment.
does the Board recommend that I vote?
Board unanimously recommends that stockholders vote "FOR" each of the Director Nominees listed in proposal No. 1 and 2 and
"FOR" each of proposals No. 3 and 4 and "THREE YEARS" for proposal No. 5.
is the difference between holding shares as a shareholder of record and as a beneficial owner?
of our Shareholders hold their shares in an account at a brokerage firm, bank or other nominee holder, rather than holding share certificates
in their own name. As summarized below, there are some distinctions between shares held of record and those owned beneficially.
of Record/Registered Shareholders
on the Record Date, your shares were registered directly in your name with our transfer agent, Vstock Transfer, you are a "Shareholder
of record" and we are sending these proxy materials directly to you. As the Shareholder of record, you have the right to direct
the voting of your shares by returning the enclosed proxy card to us. Whether or not you plan to attend the Meeting, please complete,
date and sign the enclosed proxy card to ensure that your vote is counted.
on the Record Date, your shares were held in an account at a brokerage firm or at a bank or other nominee holder, you are considered
the beneficial owner of shares held "in street name," and these proxy materials are being forwarded to you by your broker
or nominee who is considered the Shareholder of record for purposes of voting at the Meeting. As the beneficial owner, you have the right
to direct your broker on how to vote your shares and to attend the Meeting. However, since you are not the Shareholder of record, you
may not vote these shares in person unless you receive a valid proxy from your brokerage firm, bank or other nominee holder. To obtain
Last updated: Apr 27, 2022